Outcome Modifying Genes in Sickle Cell Disease

Short Name	OMG_SCD
Institution(s)	Duke University
Type of Omics	WGS
Approx. Sample Size	675
Disease/Phenotype	sickle cell disease
Starting Phase	Phase 2
TOPMed Accession #	phs001608
Omics Center(s) Phase 2	Baylor College of Medicine Human Genome Sequencing Center
Specify the TOPMed Phase for the Omics Center(s) selected above	7.1
Omics Center Contact	Donna Muzny
Phases Involved	2
PI	Allison Ashley-Koch
Co-PI	Marilyn Telen
Contact	Allison Ashley-Koch
Data Set contact(s)	Allison Ashley-Koch Marilyn Telen
COL Contact(s)	Allison Ashley-Koch Marilyn Telen
Project	OMG_SCD